Market revenue in 2022 | USD 79.1 million |
Market revenue in 2030 | USD 148.6 million |
Growth rate | 8.2% (CAGR from 2022 to 2030) |
Largest segment | Lead identification & candidate optimization |
Fastest growing segment | Other Associated Workflow |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, Other Associated Workflow |
Key market players worldwide | Albany Molecular Research, Evotec SE, Labcorp Holdings Inc, GenScript ProBio, Pharmaceutical Product Development, Charles River Laboratories International Inc, Wuxi AppTec Co Ltd, Merck & Co Inc, Thermo Fisher Scientific Inc, Dalton Pharma Services, Jubilant Biosys, Qiagen NV, Eurofins Scientific SE, Dr. Reddy’s Laboratories, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, TCG Lifesciences, Syngene, Oncodesign, DiscoveRX, Domainex |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to drug discovery outsourcing market will help companies and investors design strategic landscapes.
Lead identification & candidate optimization was the largest segment with a revenue share of 32.11% in 2022. Horizon Databook has segmented the South Africa drug discovery outsourcing market based on target identification & screening, target validation & functional informatics, lead identification & candidate optimization, preclinical development, other associated workflow covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa drug discovery outsourcing market is expected to witness growth in the coming years owing to the increasing demand for drug therapies and the presence of large un-met medical need in the region.
The Department of Science & Technology formed the Technology Innovation Agency through Technology Innovation Agency Act No. 26 in 2008, which supports the development of research in science councils, higher education institutions, & private research institutions and promotes technological innovation in the country.
Initiatives such as the African Network for Drugs and Diagnostics Innovation (ANDI), African Union (AU), and New Partnership for Africa's Development (NEPAD) try and fill research gaps in drug discovery & development and will further drive growth in this region.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa drug discovery outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into South Africa drug discovery outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account